Drug Discovery Informatics Market By Application (Drug Discovery, Drug Development), By Function (Sequencing and Target Data Analysis, Library and Database Preparation, Docking, Molecular Modelling, Others), By End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Other End Users): Global Opportunity Analysis and Industry Forecast, 2022 - 2032
The global drug discovery informatics market size was valued at $2.9 million in 2022 and is projected to reach $7.9 million by 2032, registering a CAGR of 10.5% from 2023 to 2032.m
Drug discovery informatics involves the utilization of information technology to aid researchers in the process of drug discovery and development. The key factors that drive drug discovery informatics market growth are the rise in the prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, high blood pressure, and various other diseases, the rise in R&D activities for drug discovery, and the surge in demand for target drug therapy. For instance, according to the report published by IQVIA in June 2022, it has been estimated that oncology trial starts reached historically high levels in 2021, up 56% from 2016 and mostly focused on rare cancer indications, a record 30 oncology novel active substances were initially launched globally in 2021, and a total of 159 have been launched since 2012. Thus, the rise in the number of research activities increases the demand for performing clinical trials to launch the new molecule in the market drives growth of the market.
Furthermore, the rise in usage of AI in drug discovery as well as rapid shift toward patent expiration, biologics, unprecedented downsizing of internal discovery of big pharmaceuticals, and surge in incidences of antibiotic resistance as well as drug resistance boost the growth of the market. However, the high cost of outsourcing services and stringent government regulations are the major barriers to the growth of the market. Conversely, rising cases of cancer, genetic diseases, chronic diseases, large geriatric population, favorable regulatory environment, and availability of low-cost skilled manpower with high-quality data in developing countries are expected to provide the drug discovery informatics market opportunity for growth during the forecast period.
The drug discovery informatics market is segmented into application, function, end user, and region. Based on application, the market is segmented into drug discovery and drug development. Based on function, the market is segmented into sequencing and target data analysis, library, and database preparation, docking, molecular modelling and others. Based on end users, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations and other end users. Region wise, the drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
Major companies operating in this market include Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc.
Key players have adopted partnership and collaboration as their key strategy to improve the product portfolio of the drug discovery informatics market.
Key Benefits For Stakeholders
Drug discovery informatics involves the utilization of information technology to aid researchers in the process of drug discovery and development. The key factors that drive drug discovery informatics market growth are the rise in the prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, high blood pressure, and various other diseases, the rise in R&D activities for drug discovery, and the surge in demand for target drug therapy. For instance, according to the report published by IQVIA in June 2022, it has been estimated that oncology trial starts reached historically high levels in 2021, up 56% from 2016 and mostly focused on rare cancer indications, a record 30 oncology novel active substances were initially launched globally in 2021, and a total of 159 have been launched since 2012. Thus, the rise in the number of research activities increases the demand for performing clinical trials to launch the new molecule in the market drives growth of the market.
Furthermore, the rise in usage of AI in drug discovery as well as rapid shift toward patent expiration, biologics, unprecedented downsizing of internal discovery of big pharmaceuticals, and surge in incidences of antibiotic resistance as well as drug resistance boost the growth of the market. However, the high cost of outsourcing services and stringent government regulations are the major barriers to the growth of the market. Conversely, rising cases of cancer, genetic diseases, chronic diseases, large geriatric population, favorable regulatory environment, and availability of low-cost skilled manpower with high-quality data in developing countries are expected to provide the drug discovery informatics market opportunity for growth during the forecast period.
The drug discovery informatics market is segmented into application, function, end user, and region. Based on application, the market is segmented into drug discovery and drug development. Based on function, the market is segmented into sequencing and target data analysis, library, and database preparation, docking, molecular modelling and others. Based on end users, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations and other end users. Region wise, the drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
Major companies operating in this market include Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc.
Key players have adopted partnership and collaboration as their key strategy to improve the product portfolio of the drug discovery informatics market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the drug discovery informatics market analysis from 2022 to 2032 to identify the prevailing drug discovery informatics market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the drug discovery informatics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global drug discovery informatics market trends, key players, market segments, application areas, and market growth strategies.
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- SWOT Analysis
- Drug Development
- Library and Database Preparation
- Docking
- Molecular Modelling
- Others
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- North America U.S.
- Canada
- Mexico
- Europe Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Oracle Corporation
- Accenture
- Thermo Fisher Scientific Inc.
- Certara, Inc.
- Albany Molecular Research, Inc.
- Jubilant Pharmova
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Mdoerate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising R&D Expenditure in Pharmaceutical and Biotechnology Sectors
3.4.1.2. Increasing Adoption of Artificial Intelligence and Machine Learning Solutions
3.4.1.3. Growth of High-Throughput Technologies and Big Data Generation
3.4.2. Restraints
3.4.2.1. Data Integration Challenges and Interoperability Issues
3.4.2.2. High Initial Implementation Costs and Limited Skilled Workforce
3.4.3. Opportunities
3.4.3.1. Expansion of Cloud-Based and Collaborative Informatics Platforms
CHAPTER 4: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Drug Discovery
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Drug Development
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
5.1. Overview
5.1.1. Market size and forecast
5.2. Sequencing and Target Data Analysis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Library and Database Preparation
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Docking
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Molecular Modelling
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: DRUG DISCOVERY INFORMATICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Biotechnology Companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Pharmaceutical Companies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Contract Research Organizations
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Other End Users
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: DRUG DISCOVERY INFORMATICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Application
7.2.3. Market size and forecast, by Function
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Application
7.2.5.1.2. Market size and forecast, by Function
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Application
7.2.5.2.2. Market size and forecast, by Function
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Application
7.2.5.3.2. Market size and forecast, by Function
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Application
7.3.3. Market size and forecast, by Function
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Application
7.3.5.1.2. Market size and forecast, by Function
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Application
7.3.5.2.2. Market size and forecast, by Function
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Application
7.3.5.3.2. Market size and forecast, by Function
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Application
7.3.5.4.2. Market size and forecast, by Function
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Application
7.3.5.5.2. Market size and forecast, by Function
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Application
7.3.5.6.2. Market size and forecast, by Function
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Application
7.4.3. Market size and forecast, by Function
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Application
7.4.5.1.2. Market size and forecast, by Function
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Application
7.4.5.2.2. Market size and forecast, by Function
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Application
7.4.5.3.2. Market size and forecast, by Function
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Application
7.4.5.4.2. Market size and forecast, by Function
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Application
7.4.5.5.2. Market size and forecast, by Function
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Application
7.4.5.6.2. Market size and forecast, by Function
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Application
7.5.3. Market size and forecast, by Function
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Application
7.5.5.1.2. Market size and forecast, by Function
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Application
7.5.5.2.2. Market size and forecast, by Function
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Application
7.5.5.3.2. Market size and forecast, by Function
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Application
7.5.5.4.2. Market size and forecast, by Function
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Oracle Corporation
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Accenture
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Thermo Fisher Scientific
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Certara, Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Albany Molecular Research, Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Jubilant Pharmova
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Mdoerate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising R&D Expenditure in Pharmaceutical and Biotechnology Sectors
3.4.1.2. Increasing Adoption of Artificial Intelligence and Machine Learning Solutions
3.4.1.3. Growth of High-Throughput Technologies and Big Data Generation
3.4.2. Restraints
3.4.2.1. Data Integration Challenges and Interoperability Issues
3.4.2.2. High Initial Implementation Costs and Limited Skilled Workforce
3.4.3. Opportunities
3.4.3.1. Expansion of Cloud-Based and Collaborative Informatics Platforms
CHAPTER 4: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Drug Discovery
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Drug Development
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
5.1. Overview
5.1.1. Market size and forecast
5.2. Sequencing and Target Data Analysis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Library and Database Preparation
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Docking
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Molecular Modelling
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: DRUG DISCOVERY INFORMATICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Biotechnology Companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Pharmaceutical Companies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Contract Research Organizations
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Other End Users
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: DRUG DISCOVERY INFORMATICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Application
7.2.3. Market size and forecast, by Function
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Application
7.2.5.1.2. Market size and forecast, by Function
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Application
7.2.5.2.2. Market size and forecast, by Function
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Application
7.2.5.3.2. Market size and forecast, by Function
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Application
7.3.3. Market size and forecast, by Function
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Application
7.3.5.1.2. Market size and forecast, by Function
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Application
7.3.5.2.2. Market size and forecast, by Function
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Application
7.3.5.3.2. Market size and forecast, by Function
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Application
7.3.5.4.2. Market size and forecast, by Function
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Application
7.3.5.5.2. Market size and forecast, by Function
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Application
7.3.5.6.2. Market size and forecast, by Function
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Application
7.4.3. Market size and forecast, by Function
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Application
7.4.5.1.2. Market size and forecast, by Function
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Application
7.4.5.2.2. Market size and forecast, by Function
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Application
7.4.5.3.2. Market size and forecast, by Function
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Application
7.4.5.4.2. Market size and forecast, by Function
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Application
7.4.5.5.2. Market size and forecast, by Function
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Application
7.4.5.6.2. Market size and forecast, by Function
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Application
7.5.3. Market size and forecast, by Function
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Application
7.5.5.1.2. Market size and forecast, by Function
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Application
7.5.5.2.2. Market size and forecast, by Function
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Application
7.5.5.3.2. Market size and forecast, by Function
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Application
7.5.5.4.2. Market size and forecast, by Function
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Oracle Corporation
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Accenture
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Thermo Fisher Scientific
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Certara, Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Albany Molecular Research, Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Jubilant Pharmova
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 02. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY REGION, 2022-2032 ($MILLION)
TABLE 03. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 05. DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY REGION, 2022-2032 ($MILLION)
TABLE 07. DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY REGION, 2022-2032 ($MILLION)
TABLE 09. DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 11. DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 12. DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 21. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 22. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 25. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 31. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 34. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 35. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 38. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. UK DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 41. UK DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 44. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 47. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 57. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 59. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 60. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 66. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 75. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 78. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. ORACLE CORPORATION: KEY EXECUTIVES
TABLE 90. ORACLE CORPORATION: COMPANY SNAPSHOT
TABLE 91. ORACLE CORPORATION: PRODUCT SEGMENTS
TABLE 92. ORACLE CORPORATION: SERVICE SEGMENTS
TABLE 93. ORACLE CORPORATION: PRODUCT PORTFOLIO
TABLE 94. ORACLE CORPORATION: KEY STRATERGIES
TABLE 95. ACCENTURE: KEY EXECUTIVES
TABLE 96. ACCENTURE: COMPANY SNAPSHOT
TABLE 97. ACCENTURE: PRODUCT SEGMENTS
TABLE 98. ACCENTURE: SERVICE SEGMENTS
TABLE 99. ACCENTURE: PRODUCT PORTFOLIO
TABLE 100. ACCENTURE: KEY STRATERGIES
TABLE 101. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
TABLE 102. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 103. THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 104. THERMO FISHER SCIENTIFIC: SERVICE SEGMENTS
TABLE 105. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 106. THERMO FISHER SCIENTIFIC: KEY STRATERGIES
TABLE 107. CERTARA, INC.: KEY EXECUTIVES
TABLE 108. CERTARA, INC.: COMPANY SNAPSHOT
TABLE 109. CERTARA, INC.: PRODUCT SEGMENTS
TABLE 110. CERTARA, INC.: SERVICE SEGMENTS
TABLE 111. CERTARA, INC.: PRODUCT PORTFOLIO
TABLE 112. CERTARA, INC.: KEY STRATERGIES
TABLE 113. ALBANY MOLECULAR RESEARCH, INC.: KEY EXECUTIVES
TABLE 114. ALBANY MOLECULAR RESEARCH, INC.: COMPANY SNAPSHOT
TABLE 115. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT SEGMENTS
TABLE 116. ALBANY MOLECULAR RESEARCH, INC.: SERVICE SEGMENTS
TABLE 117. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT PORTFOLIO
TABLE 118. ALBANY MOLECULAR RESEARCH, INC.: KEY STRATERGIES
TABLE 119. JUBILANT PHARMOVA: KEY EXECUTIVES
TABLE 120. JUBILANT PHARMOVA: COMPANY SNAPSHOT
TABLE 121. JUBILANT PHARMOVA: PRODUCT SEGMENTS
TABLE 122. JUBILANT PHARMOVA: SERVICE SEGMENTS
TABLE 123. JUBILANT PHARMOVA: PRODUCT PORTFOLIO
TABLE 124. JUBILANT PHARMOVA: KEY STRATERGIES
TABLE 01. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 02. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY REGION, 2022-2032 ($MILLION)
TABLE 03. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 05. DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY REGION, 2022-2032 ($MILLION)
TABLE 07. DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY REGION, 2022-2032 ($MILLION)
TABLE 09. DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 11. DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 12. DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 21. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 22. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 25. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 31. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 34. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 35. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 38. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. UK DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 41. UK DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 44. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 47. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 57. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 59. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 60. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 66. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 75. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 78. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. ORACLE CORPORATION: KEY EXECUTIVES
TABLE 90. ORACLE CORPORATION: COMPANY SNAPSHOT
TABLE 91. ORACLE CORPORATION: PRODUCT SEGMENTS
TABLE 92. ORACLE CORPORATION: SERVICE SEGMENTS
TABLE 93. ORACLE CORPORATION: PRODUCT PORTFOLIO
TABLE 94. ORACLE CORPORATION: KEY STRATERGIES
TABLE 95. ACCENTURE: KEY EXECUTIVES
TABLE 96. ACCENTURE: COMPANY SNAPSHOT
TABLE 97. ACCENTURE: PRODUCT SEGMENTS
TABLE 98. ACCENTURE: SERVICE SEGMENTS
TABLE 99. ACCENTURE: PRODUCT PORTFOLIO
TABLE 100. ACCENTURE: KEY STRATERGIES
TABLE 101. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
TABLE 102. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 103. THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 104. THERMO FISHER SCIENTIFIC: SERVICE SEGMENTS
TABLE 105. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 106. THERMO FISHER SCIENTIFIC: KEY STRATERGIES
TABLE 107. CERTARA, INC.: KEY EXECUTIVES
TABLE 108. CERTARA, INC.: COMPANY SNAPSHOT
TABLE 109. CERTARA, INC.: PRODUCT SEGMENTS
TABLE 110. CERTARA, INC.: SERVICE SEGMENTS
TABLE 111. CERTARA, INC.: PRODUCT PORTFOLIO
TABLE 112. CERTARA, INC.: KEY STRATERGIES
TABLE 113. ALBANY MOLECULAR RESEARCH, INC.: KEY EXECUTIVES
TABLE 114. ALBANY MOLECULAR RESEARCH, INC.: COMPANY SNAPSHOT
TABLE 115. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT SEGMENTS
TABLE 116. ALBANY MOLECULAR RESEARCH, INC.: SERVICE SEGMENTS
TABLE 117. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT PORTFOLIO
TABLE 118. ALBANY MOLECULAR RESEARCH, INC.: KEY STRATERGIES
TABLE 119. JUBILANT PHARMOVA: KEY EXECUTIVES
TABLE 120. JUBILANT PHARMOVA: COMPANY SNAPSHOT
TABLE 121. JUBILANT PHARMOVA: PRODUCT SEGMENTS
TABLE 122. JUBILANT PHARMOVA: SERVICE SEGMENTS
TABLE 123. JUBILANT PHARMOVA: PRODUCT PORTFOLIO
TABLE 124. JUBILANT PHARMOVA: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF DRUG DISCOVERY INFORMATICS MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN DRUG DISCOVERY INFORMATICS MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN DRUG DISCOVERY INFORMATICS MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MDOERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. DRUG DISCOVERY INFORMATICS MARKET BY REGION, 2022 AND 2032(%)
FIGURE 26. U.S. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 27. CANADA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 29. GERMANY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 30. FRANCE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 31. UK DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 32. ITALY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 33. SPAIN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 34. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 35. JAPAN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 36. CHINA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 37. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 38. INDIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 41. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 42. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 43. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 44. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR (2023-2023)
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT (2023-2023)
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY (2023-2023)
FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49. COMPETITIVE DASHBOARD
FIGURE 50. COMPETITIVE HEATMAP: DRUG DISCOVERY INFORMATICS MARKET
FIGURE 51. TOP PLAYER POSITIONING, 2022
FIGURE 01. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF DRUG DISCOVERY INFORMATICS MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN DRUG DISCOVERY INFORMATICS MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN DRUG DISCOVERY INFORMATICS MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MDOERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. DRUG DISCOVERY INFORMATICS MARKET BY REGION, 2022 AND 2032(%)
FIGURE 26. U.S. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 27. CANADA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 29. GERMANY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 30. FRANCE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 31. UK DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 32. ITALY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 33. SPAIN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 34. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 35. JAPAN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 36. CHINA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 37. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 38. INDIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 41. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 42. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 43. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 44. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR (2023-2023)
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT (2023-2023)
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY (2023-2023)
FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49. COMPETITIVE DASHBOARD
FIGURE 50. COMPETITIVE HEATMAP: DRUG DISCOVERY INFORMATICS MARKET
FIGURE 51. TOP PLAYER POSITIONING, 2022
